Facebook
Twitter
LinkedIn
Forward
340B Drug Pricing Program and HCV Treatment
| Registration |
|---|
The HCV ECHO is a tele-mentoring program that uses videoconferencing technology (Zoom) to combine MAT didactic presentations with interactive and practical HCV case presentations from participants. To register, email ECHO@iowapca.org the following information: Name, title, credentials, organization name, and email address. |
Target Audience
Providers and clinical staff who are interested in providing treatment and care to individuals diagnosed with Hepatitis C (providers, nursing, behavioral health, linkage navigators, front desk/scheduling, admin, etc.).
Purpose
This interactive web-based program provides community-focused primary care clinicians an opportunity to become experts in the delivery of Hepatitis C care through a mentoring-based initiative. Project ECHO, developed by Dr. Sanjeev Aurora at the University of New Mexico (UNM) in 2003, provides a framework for sharing expertise across the state and as a result will help patients achieve a viral cure and avoid the downstream sequela associated with HCV without leaving the providers they trust and the communities where they live and work. Interested providers do not have to have any prior experience in treating Hepatitis C to participate in HCV ECHO.
The mission is to help centers and primary care providers manage HCV patients at their primary care center to alleviate barriers to care for un/underinsured patients by increasing the providers’ abilities to treat their patients at their primary care health center.
Professional Practice Gap
Iowa Medicaid requires medication treatment for HCV be prescribed by or in consult with a specialist. This creates a barrier to care for un/underinsured patients and a gap in care for patients and primary care providers that do not have access to specialists in their communities where specialists (infectious disease/hepatologists) are scarce or will only see a limited number of Medicaid patients.
The HCV ECHO will allow primary care providers to meet the prescribing requirement for Medicaid patients and to consult with specialists for all of their patients with HCV to allow the patients to be treated by their PCP at their local health center thus decreasing barriers to care and increasing positive health outcomes. The ECHO model allows for PCPs to increase their knowledge and skill set regarding Hepatitis C treatment and care through the didactic sessions and mentoring from specialists.
Learning Objectives
- Provide HCV care and treatment within primary care.
- Develop workflows, prior authorization for medication requirements and example protocols.
- Learn the different phases of HCV care including determining fibro score; treatment course; harm reduction strategies and follow up care.
Agenda
| 11:45 am | Didactic Sessions Topics may include:
|
| 12:30 pm | Case Presentations You do not need to present a case during every session in order to participate in the HCV clinic. However, the submission of cases for presentation and discussion is a key component in the Project ECHO model and critically important for knowledge building and sharing, and it is therefore required that each provider present at minimum three cases per year. We welcome cases that involve common clinical scenarios related to HCV diagnosis and care as well as difficult, complex, or challenging presentations and patient management scenarios. |
Speaker
Jeffrey I. Davis
Of Counsel/Senior Advisor, Baker Donelson
Prior to joining the Firm, Mr. Davis served as vice president and legislative and policy counsel for 340B Health, a nonprofit organization of more than 1,300 hospitals and health systems participating in the 340B drug pricing program. During his more than seven years with 340B Health, he provided hospitals with technical assistance on 340B, Medicare, and Medicaid program compliance issues, oversaw research and policy efforts, and helped lead the government relations team in their work to educate members of Congress and their staff on the importance of the 340B program to hospitals and their patients. Mr. Davis is also a frequent speaker at major industry forums, making regular presentations at annual 340B Coalition conferences, state hospital association meetings, drug manufacturer conferences, and other professional association events.
Mr. Davis previously served as the health care legislative assistant for U.S. Representative Shelley Berkley (D-NV), where he advised Rep. Berkley on health care issues and legislation before Congress and the House Ways and Means Committee and partnered with health care providers to promote increased Medicare funding for hospitals, physicians, nursing homes, acute care and long term care facilities, and other providers.
HCV ECHO HUB TEAM
- Donald Hillebrand, MD, Medical Director, UnityPoint Health – Center for Liver Disease
- Steven Donnelly, PharmD, Community A Walgreens Specialty Pharmacy
- Mark Hillenbrand, LISW, RCSW, Authentic Freedom Counseling Center
- Megan Srinivas, MD, Infectious Disease, Community Health Centers of Fort Dodge
- Malissa S. Sprenger, MS, IAADC, Coordinator, Turning Point Treatment Center
ECHO Coordinators
- Julie Baker, Director of Preventive Services, Iowa Primary Care Association
- Chelsea Miller, Administrative Assistant, Iowa Primary Care Association
Accreditation Statements
MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University 
(DMU) and the Iowa Primary Care Association. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live, online activity for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.- DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this program for a maximum of 1.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- Other Healthcare Professionals: This live activity is designated for a maximum of 1.5 AMA PRA Category 1 Credit(s)™.
EDUCATIONAL GRANTS
No commercial interest company provided financial support for this continuing education activity.
DISCLOSURE
Relevant to the content of this educational activity, the planning committee members and speaker indicated they have no financial relationships with commercial interests to disclose. The speaker will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). Determination of educational content and the selection of speakers is the responsibility of the activity director. Firms providing financial support did not have input in these areas.
Disclaimer
The information provided at this activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.
Available Credit
- 1.50 AMA PRA Category 1 Credits™
- 1.50 AOA Category 2A
- 1.50 CE Contact Hour(s)
Price
There is no cost to attend. Sessions are the third Tuesday of the month.
The HCV ECHO is a tele-mentoring program that uses videoconferencing technology (Zoom) to combine MAT didactic presentations with interactive and practical HCV case presentations from participants.
To register, email ECHO@iowapca.org the following information: Name, title, credentials, organization name, and email address.